1134-8046

S1134-80462017000400188

10.20986/resed.2017.3586/2017

España

00 08 2017

24 4 188 200

1963 13

502-7

2008 11

S133-53

2006 13 ^s1 ^s1 1

13-33

2014 31 7 7

657-82

2010 2

742-4

2014 15 12 12

1215-26

1992 7 7 7

419-30

2009 16 1 1

21-8

1989 71

615-7

1988 68 5 5

671-5

1992 77 2 2

281-5

2014 15 6 6

602-7

Working Group Nientemale DEI 2016 76 3 3

315-30

2013 20 2 2

61-8

2012 5

559-66

2012 14 7 7

499-504

1989 3 8 8

25-9

2016 23 1 1

3-5

National Institute for Health and Care Excellence 4-year surveillance 2016

2012 7 2 2

113-20

Breakthrough/Episodic Pain Italian Study Group 2012 43 5 5

833-41

2013 110 16 16

271-7

2013 11 ^s1 ^s1 1

S37-43

2012 72 2 2

181-90

IOPS MS study Group 2016 24 2 2

961-8

2016 23 2 2

96-108

2013 46

573-80

2016

27-39

2013 15 7 7

526-34

2011 58 7 7

462-4

2010 16

641-52

2011 3 ^s2 ^s2 2

18-22

2014 80 10 10

1123-34

2012 26 6 6

509-35

1998 90 8 8

611-6

2001 91 1-2 1-2

123-30

2012 12 4 4

307-14

2015 29 3 3

228-46

2006 2 9 9

805-11

2007 5 7 7

327-34

2010 10 4 4

287-93

2011 112 3 3

693-702

2010 11 7 7

1017-23

2010 21 6 6

1308-14

2009 140

2-11

2012 13

1110-5

2009 25 12 12

2877-85

2005 59 2 2

249-53

2010 24 3 3

286-93

2014 31 1 1

107-17

2014 10 1 1

12-6

ETHYFYL Study Group 2014 36

357-67

2013 51 5 5

349-56

1999 289 2 2

1084-9

2008 42 10 10

1380-7

2010 6 1 1

17-26

2008 64 5 5

497-502

2009 31 6 6

1177-91

2009 25 11 11

2805-15

2015 37 3 3

585-96

2009 6 5 5

543-52

2010 48 12 12

860-7

2013 15 1 1

40-5

2011 25 6 6

511-22

2012 161 2 2

254-63

2010 48 2 2

138-45

2012 134

366-79

2013 6 1 1

9-22

Fentanyl Pectin Nasal Spray 043 Study Group 2010 151 3 3

617-24

Fentanyl Nasal Spray Study 044 Investigators Group 2011 9 6 6

224-31

2016 52 1 1

27-34

2011 27 1 1

9-18

2004 6 2 2

2007 10 1 1

47-55

2013 11 1 1

s29-36

2000 20 2 2

87-92